|
|
||||||||



* Institut National de la Santé et de la Recherche Médicale E0109,
Service de Médecine Interne, and
Institut National de la Santé et de la Recherche Médicale Unité 569, Hôpital Bicêtre, Le Kremlin-Bicêtre, and
Laboratoire de Virologie Hôpital Necker, Paris, France
Primary viral infections, including primary HIV infection, trigger intense activation of the immune system, with marked expansion of CD38+CD8+ T cells. Whether this expansion involves only viral-specific cells or includes a degree of bystander activation remains a matter of debate. We therefore examined the activation status of EBV-, CMV-, and influenza virus (FLU)-specific CD8+ T cells during primary HIV infection, in comparison to HIV-specific CD8+ T cells. The activation markers CD38 and HLA-DR were strongly expressed on HIV-specific CD8+ T cells. Surprisingly, CD38 expression was also up-regulated on CD8+ T cells specific for other viruses, albeit to a lesser extent. Activation marker expression returned to normal or near-normal values after 1 year of highly active antiretroviral therapy. HIV viral load correlated with CD38 expression on HIV-specific CD8+ T cells but also on EBV-, CMV-, and FLU-specific CD8+ T cells. In primary HIV infection, EBV-specific CD8+ T cells also showed increased Ki67 expression and decreased Bcl-2 expression, compared with values observed in HIV-seronegative control subjects. These results show that bystander activation occurs during primary HIV infection, even though HIV-specific CD8+ T cells express the highest level of activation. The role of this bystander activation in lymphocyte homeostasis and HIV pathogenesis remains to be determined.
This article has been cited by other articles:
![]() |
W. A. Burgers, C. Riou, M. Mlotshwa, P. Maenetje, D. de Assis Rosa, J. Brenchley, K. Mlisana, D. C. Douek, R. Koup, M. Roederer, et al. Association of HIV-Specific and Total CD8+ T Memory Phenotypes in Subtype C HIV-1 Infection with Viral Set Point J. Immunol., April 15, 2009; 182(8): 4751 - 4761. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lecuroux, I. Girault, A. Urrutia, J.-M. Doisne, C. Deveau, C. Goujard, L. Meyer, M. Sinet, and A. Venet Identification of a particular HIV-specific CD8+ T-cell subset with a CD27+ CD45RO-/RA+ phenotype and memory characteristics after initiation of HAART during acute primary HIV infection Blood, April 2, 2009; 113(14): 3209 - 3217. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Catalfamo, M. Di Mascio, Z. Hu, S. Srinivasula, V. Thaker, J. Adelsberger, A. Rupert, M. Baseler, Y. Tagaya, G. Roby, et al. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells PNAS, December 16, 2008; 105(50): 19851 - 19856. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tuuminen, E. Kekalainen, S. Makela, I. Ala-Houhala, F. A. Ennis, K. Hedman, J. Mustonen, A. Vaheri, and T. P. Arstila Human CD8+ T Cell Memory Generation in Puumala Hantavirus Infection Occurs after the Acute Phase and Is Associated with Boosting of EBV-Specific CD8+ Memory T Cells J. Immunol., August 1, 2007; 179(3): 1988 - 1995. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Saez-Cirion, C. Lacabaratz, O. Lambotte, P. Versmisse, A. Urrutia, F. Boufassa, F. Barre-Sinoussi, J.-F. Delfraissy, M. Sinet, G. Pancino, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype PNAS, April 17, 2007; 104(16): 6776 - 6781. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Petrovas, Y. M. Mueller, I. D. Dimitriou, S. R. Altork, A. Banerjee, P. Sklar, K. C. Mounzer, J. D. Altman, and P. D. Katsikis Increased mitochondrial mass characterizes the survival defect of HIV-specific CD8+ T cells Blood, March 15, 2007; 109(6): 2505 - 2513. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Masopust, K. Murali-Krishna, and R. Ahmed Quantitating the Magnitude of the Lymphocytic Choriomeningitis Virus-Specific CD8 T-Cell Response: It Is Even Bigger than We Thought J. Virol., February 15, 2007; 81(4): 2002 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Samri, C. Durier, A. Urrutia, I. Sanchez, H. Gahery-Segard, S. Imbart, M. Sinet, E. Tartour, J.-P. Aboulker, B. Autran, et al. Evaluation of the Interlaboratory Concordance in Quantification of Human Immunodeficiency Virus-Specific T Cells with a Gamma Interferon Enzyme-Linked Immunospot Assay Clin. Vaccine Immunol., June 1, 2006; 13(6): 684 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Zaunders, M. L. Munier, D. E. Kaufmann, S. Ip, P. Grey, D. Smith, T. Ramacciotti, D. Quan, R. Finlayson, J. Kaldor, et al. Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection Blood, September 1, 2005; 106(5): 1660 - 1667. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |